XR Securities’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,500
Closed -$231K 349
2023
Q4
$231K Buy
+4,500
New +$236K 0.01% 364
2023
Q2
Sell
-11,200
Closed -$776K 390
2023
Q1
$776K Sell
11,200
-1,400
-11% -$98.7K 0.02% 213
2022
Q4
$907K Buy
+12,600
New +$950K 0.09% 180
2022
Q2
Sell
-18,200
Closed -$3K 383
2022
Q1
$3K Buy
+18,200
New +$1.22M ﹤0.01% 332
2021
Q1
Sell
-18,700
Closed -$37K 478
2020
Q4
$37K Buy
+18,700
New +$1.15M ﹤0.01% 326
2020
Q3
Sell
-13,200
Closed -$32K 291
2020
Q2
$32K Buy
13,200
+2,000
+18% +$120K ﹤0.01% 195
2020
Q1
$13K Sell
11,200
-40,400
-78% -$2.47M ﹤0.01% 183
2019
Q4
$5K Buy
51,600
+29,800
+137% +$1.71M ﹤0.01% 214
2019
Q3
$30K Sell
21,800
-14,500
-40% -$681K ﹤0.01% 179
2019
Q2
$117K Sell
36,300
-36,700
-50% -$1.71M 0.02% 160
2019
Q1
$92K Buy
73,000
+50,500
+224% +$2.52M 0.01% 175
2018
Q4
$109K Buy
22,500
+8,000
+55% +$430K 0.05% 163
2018
Q3
$24K Buy
14,500
+4,500
+45% +$267K 0.01% 277
2018
Q2
$38K Buy
+10,000
New +$540K 0.01% 173

Other funds holding BMY

XR Securities's BMY Position: Q1 2024 in Review

XR Securities sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 3,902 shares — an estimated $200K sold.

XR Securities first reported a position in BMY in Q2 2019 and held it in 9 quarters. The position peaked at $1.44M in Q4 2019. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • XR Securities reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • XR Securities sold 3,902 Bristol-Myers Squibb shares in Q1 2024, an estimated $200K.
  • XR Securities first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 9 quarters.
  • XR Securities's Bristol-Myers Squibb position peaked at $1.44M in Q4 2019.
  • 2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on XR Securities's 13F filing for Q1 2024, filed 8 May 2024.